Cargando…
Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
Patients with primary immunodeficiency can be prone to severe Epstein–Barr virus (EBV) associated immune dysregulation. Individuals with mutations in the interleukin-2-inducible T-cell kinase (ITK) gene experience Hodgkin and non-Hodgkin lymphoma, EBV lymphoproliferative disease, hemophagocytic lymp...
Autores principales: | Ghosh, Sujal, Drexler, Ingo, Bhatia, Sanil, Adler, Heiko, Gennery, Andrew R., Borkhardt, Arndt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951928/ https://www.ncbi.nlm.nih.gov/pubmed/29867957 http://dx.doi.org/10.3389/fimmu.2018.00979 |
Ejemplares similares
-
Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
por: Ghosh, Sujal, et al.
Publicado: (2018) -
Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects
por: Ghosh, Sujal, et al.
Publicado: (2014) -
Arenaviruses: Old viruses present new solutions for cancer therapy
por: Stachura, Paweł, et al.
Publicado: (2023) -
ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection
por: Samreen, Baila, et al.
Publicado: (2019) -
Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
por: Smith, C. I. Edvard, et al.
Publicado: (2021)